Therefore, LTE prevented age-related accelerated decline of cardiac contractility and age-related accelerated increase of arrhythmias induced by HSSO, and the mechanism of that may be related to down-regulation of oxidative stress/dTOR pathway and up-regulation of heart dFOXO/PGC-1α pathway. The gene discussed is PPARGC1A; the disease is cardiac arrhythmia.